[go: up one dir, main page]

CN1299283A - 包含l－肉毒碱或烷酰基l－肉毒碱和nadh和/或nadph的组合物 - Google Patents

包含l－肉毒碱或烷酰基l－肉毒碱和nadh和/或nadph的组合物 Download PDF

Info

Publication number
CN1299283A
CN1299283A CN99805644A CN99805644A CN1299283A CN 1299283 A CN1299283 A CN 1299283A CN 99805644 A CN99805644 A CN 99805644A CN 99805644 A CN99805644 A CN 99805644A CN 1299283 A CN1299283 A CN 1299283A
Authority
CN
China
Prior art keywords
carnitine
nadh
compositions
alkanoyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99805644A
Other languages
English (en)
Chinese (zh)
Inventor
C·卡瓦加
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau HealthScience SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Publication of CN1299283A publication Critical patent/CN1299283A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN99805644A 1998-04-17 1999-04-14 包含l－肉毒碱或烷酰基l－肉毒碱和nadh和/或nadph的组合物 Pending CN1299283A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM98A000238 1998-04-17
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph

Publications (1)

Publication Number Publication Date
CN1299283A true CN1299283A (zh) 2001-06-13

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99805644A Pending CN1299283A (zh) 1998-04-17 1999-04-14 包含l－肉毒碱或烷酰基l－肉毒碱和nadh和/或nadph的组合物

Country Status (17)

Country Link
EP (1) EP1071424A1 (is)
JP (1) JP2002512191A (is)
KR (1) KR20010042765A (is)
CN (1) CN1299283A (is)
AU (1) AU750645B2 (is)
BR (1) BR9909712A (is)
CA (1) CA2328331A1 (is)
EE (1) EE200000601A (is)
HU (1) HUP0101914A3 (is)
IL (1) IL139014A0 (is)
IS (1) IS5663A (is)
IT (1) IT1299161B1 (is)
NO (1) NO20005128L (is)
PL (1) PL343482A1 (is)
SK (1) SK15442000A3 (is)
TR (1) TR200002894T2 (is)
WO (1) WO1999053921A1 (is)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101677912A (zh) * 2007-05-11 2010-03-24 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
WO2016131320A1 (zh) * 2015-02-17 2016-08-25 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
CN109496154A (zh) * 2017-12-22 2019-03-19 邦泰生物工程(深圳)有限公司 一种nadh复方组合物及其制剂和应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
US20120214870A1 (en) * 2009-08-31 2012-08-23 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
WO2019200491A1 (de) 2018-04-20 2019-10-24 Pacotrade Ag Vorrichtung zum zerkleinern von in blockform bereitgestellten tiefgefrorenen lebensmitteln
EP3864969A4 (en) * 2018-10-10 2022-06-15 Leung, So Ngor Sally MEDICINAL COMPOSITION FOR SUPPLEMENTING DEFICIENCIES, PROCESS FOR THEIR PREPARATION AND ITS APPLICATION
CN117958433A (zh) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 不含咖啡因的抗疲劳功能组合物、饮料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (is) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101677912A (zh) * 2007-05-11 2010-03-24 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
WO2016062125A1 (zh) * 2014-10-23 2016-04-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
WO2016131320A1 (zh) * 2015-02-17 2016-08-25 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
CN109496154A (zh) * 2017-12-22 2019-03-19 邦泰生物工程(深圳)有限公司 一种nadh复方组合物及其制剂和应用
WO2019119445A1 (zh) * 2017-12-22 2019-06-27 邦泰生物工程(深圳)有限公司 一种nadh复方组合物及其制剂和应用
US10894059B2 (en) 2017-12-22 2021-01-19 Bontac Bio-Engineering (Shenzhen) Co., Ltd NADH compound composition, and preparation and use thereof
CN109496154B (zh) * 2017-12-22 2021-07-06 邦泰生物工程(深圳)有限公司 一种nadh复方组合物及其制剂和应用
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法

Also Published As

Publication number Publication date
KR20010042765A (ko) 2001-05-25
PL343482A1 (en) 2001-08-27
IT1299161B1 (it) 2000-02-29
CA2328331A1 (en) 1999-10-28
JP2002512191A (ja) 2002-04-23
SK15442000A3 (sk) 2001-06-11
EP1071424A1 (en) 2001-01-31
AU750645B2 (en) 2002-07-25
IL139014A0 (en) 2001-11-25
TR200002894T2 (tr) 2001-01-22
BR9909712A (pt) 2000-12-26
IS5663A (is) 2000-10-13
NO20005128D0 (no) 2000-10-12
ITRM980238A1 (it) 1999-10-17
HUP0101914A3 (en) 2002-12-28
EE200000601A (et) 2002-04-15
NO20005128L (no) 2000-12-18
WO1999053921A1 (en) 1999-10-28
AU3442899A (en) 1999-11-08
ITRM980238A0 (it) 1998-04-17
HUP0101914A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
EP1948155B1 (en) Pharmaceutical compositions comprising droxidopa
CN1216635C (zh) 治疗糖尿病的组合物与方法
CN1251496A (zh) 用于促进骨骼肌适应剧烈运动和对抗虚弱个体疲劳过度的营养增补剂
JPH01294688A (ja) パーキンソン症候群の治療用医薬、およびその製造方法
EP2875736B1 (en) N-Carbamoylputrescine to enhance muscle protein synthesis
CN1299283A (zh) 包含l－肉毒碱或烷酰基l－肉毒碱和nadh和/或nadph的组合物
US20250108020A1 (en) Compositions and compounds containng beta-hydroxybutyrate and one or more amino acids
CN104667283B (zh) 一种治疗血脂异常和动脉粥样硬化的复方药物组合
KR100817348B1 (ko) 심부전 치료에 적합한 아미노산 기초 조성물
CN104415023A (zh) 预防或/和治疗胰岛素抵抗及相关病症的组合物
JP2008509170A (ja) カルビドパ／ベンセラジドを含むｌ−トリプトファンの新規製剤
US9533946B1 (en) N-carbamoylputrescine to enhance muscle protein synthesis
HK1036589A (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
MXPA00009983A (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
US20250332128A1 (en) Compositions and compounds containng ketone bodies and/or ketone body precursors and one or more amino acids
CN114557992B (zh) 一种复方药物组合物在制备治疗间质性肺炎药物中的应用
CZ20003831A3 (cs) Přípravek obsahující L-karnitin nebo alkanoyl Lkarnitinu a NADH a/nebo NADPH
CN1365279A (zh) 用于降低身体运动期间耗氧量的制剂
JP2009539941A (ja) Ｓｌｖ３０８およびｌ−ｄｏｐａを含んでなる組み合わせ製剤
US20250161270A1 (en) Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor
WO2005089765A1 (en) Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes
CN105530929B (zh) 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途
HK1026124B (en) Nutritional supplement
HK1031174B (en) Compositions and methods for treating diabetes
CN101478990A (zh) 包含联苯芦诺和左旋多巴的组合制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1036589

Country of ref document: HK